IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Breast Cancer Treatment

IPN, New Delhi can facilitate Breast Cancer patient to “import of  Medicines For Breast Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Indian Pharma Network

M: +91-9891296838 / 9811747774
E:  med@indianpharmanetwork.co.in

Breast Cancer Treatment

Breast cancer is a type of cancer that develops in the breast tissue. It is the most common cancer in women worldwide, although it can also occur in men. Breast cancer can start in different parts of the breast, such as the ducts that carry milk to the nipple, or the glands that produce milk. It can also spread to other parts of the body, such as the lymph nodes, bones, liver, or lungs.

The exact cause of breast cancer is not fully understood, but several factors can increase the risk of developing it, such as age, family history, hormonal factors, lifestyle habits, and exposure to certain chemicals. The symptoms of breast cancer can include a lump or thickening in the breast or armpit, changes in the size or shape of the breast, nipple discharge, and skin changes, such as redness, swelling, or dimpling.

Early detection and treatment of breast cancer are important for improving the chances of survival. Screening tests, such as mammograms, can help detect breast cancer before symptoms appear. Treatment options for breast cancer may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy, depending on the stage and type of cancer.

There are several types of medications that can be used in the treatment of breast cancer, depending on the type and stage of the cancer, as well as other individual factors. Some of the most common types of medications used for breast cancer treatment include:

Get Access FDA Approved Medicines For Breast Cancer Treatment

There are several chemotherapy medications that are commonly used for breast cancer treatment. Some of the most commonly used chemotherapy drugs for breast cancer include:

  • Anthracyclines:
    Anthracyclines are a type of chemotherapy drug that work by damaging the DNA in cancer cells, which can help to slow or stop their growth. Doxorubicin is an example of an anthracycline drug that is often used in breast cancer treatment.
  • Taxanes:
    Taxanes are another type of chemotherapy drug that are commonly used in breast cancer treatment. They work by interfering with the way cancer cells divide, which can help to slow or stop their growth. Examples of taxanes used in breast cancer treatment include paclitaxel and docetaxel.
  • Cyclophosphamide:
    Cyclophosphamide is a type of chemotherapy drug that works by damaging the DNA in cancer cells, which can help to slow or stop their growth. It is often used in combination with other chemotherapy drugs, such as anthracyclines or taxanes.
  • Fluorouracil:
    Fluorouracil is a type of chemotherapy drug that works by interfering with the way cancer cells divide, which can help to slow or stop their growth. It is often used in combination with other chemotherapy drugs for breast cancer treatment.

Other chemotherapy drugs that may be used for breast cancer treatment include carboplatin, gemcitabine, and vinorelbine. The specific chemotherapy medications used for breast cancer treatment can vary depending on the stage and subtype of the cancer, as well as other individual factors.

Targeted therapy medications are designed to specifically target and attack cancer cells while minimizing harm to healthy cells. There are several targeted therapy medications that are commonly used in the treatment of breast cancer. Some examples include:

  • Herceptin (trastuzumab):
    Herceptin is a targeted therapy medication that is used for the treatment of breast cancer that is HER2-positive. HER2 is a protein that is overexpressed in some types of breast cancer, and Herceptin works by attaching to the HER2 protein and blocking its activity, which can help to slow or stop the growth of the cancer cells.
  • Perjeta (pertuzumab):
    Perjeta is another targeted therapy medication that is used in combination with Herceptin for the treatment of HER2-positive breast cancer. Perjeta works by targeting a different part of the HER2 protein than Herceptin, which can help to further block its activity and slow the growth of cancer cells.
  • Kadcyla (ado-trastuzumab emtansine):
    Kadcyla is a targeted therapy medication that is also used for the treatment of HER2-positive breast cancer. It is a combination of Herceptin and a chemotherapy drug, and is designed to deliver the chemotherapy directly to the cancer cells while minimizing harm to healthy cells.
  • CDK4/6 inhibitors:
    CDK4/6 inhibitors, such as Palbociclib, Ribociclib and Abemaciclib, are a type of targeted therapy medication that are used in combination with hormone therapy for the treatment of hormone receptor-positive breast cancer. They work by blocking the activity of certain proteins that can stimulate the growth of cancer cells, which can help to slow or stop their growth.

Other targeted therapy medications that may be used for breast cancer treatment include mTOR inhibitors, PI3K inhibitors, and PARP inhibitors. The specific targeted therapy medications used for breast cancer treatment can vary depending on the subtype of the cancer and other individual factors.

Immunotherapy medications are a newer type of treatment for breast cancer, and are designed to help the body’s own immune system fight against cancer cells. There are several immunotherapy medications that are currently being used or tested for the treatment of breast cancer. Some examples include:

  • Pembrolizumab:
    Pembrolizumab is a type of immunotherapy medication known as a PD-1 inhibitor. It works by blocking a protein called PD-1 on immune cells, which can help to activate the immune system to attack cancer cells. Pembrolizumab is currently approved for the treatment of certain types of metastatic breast cancer.
  • Atezolizumab:
    Atezolizumab is another type of immunotherapy medication that is used for the treatment of certain types of metastatic breast cancer. It is a type of PD-L1 inhibitor, which works by blocking the activity of a protein called PD-L1 on cancer cells, which can help to activate the immune system to attack the cancer cells.
  • Tucatinib:
    Tucatinib is a newer type of immunotherapy medication that is used for the treatment of HER2-positive breast cancer. It is a type of TKI (tyrosine kinase inhibitor) that works by blocking the activity of HER2 on cancer cells, which can help to slow or stop their growth. Tucatinib also has some immune-modulating effects that can help to activate the immune system to attack cancer cells.

Other types of immunotherapy medications that are being tested for the treatment of breast cancer include CAR-T cell therapy, which involves genetically modifying a patient’s own T cells to target cancer cells, and cancer vaccines, which are designed to help the immune system recognize and attack cancer cells. The specific immunotherapy medications used for breast cancer treatment can vary depending on the subtype of the cancer and other individual factors.

Hormone therapy is used for breast cancers that are hormone receptor positive. These drugs work by blocking the action of hormones, such as estrogen, that can stimulate the growth of breast cancer cells. Some common hormone therapies for breast cancer include tamoxifen, aromatase inhibitors, and fulvestrant.

It’s important to note that the specific medications used in breast cancer treatment can vary based on the individual patient’s circumstances and the specifics of their cancer, so treatment plans may differ between patients.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Breast Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398